EMA and national agencies outline their vision of the future regulatory network
This article was originally published in Scrip
Executive Summary
EU regulators have sketched out the future challenges facing the European regulatory network and its stakeholders over the coming five years and more, and have come up with solutions aimed at allowing innovation to be fostered while protecting public health and pursuing greater global collaboration and the wider adoption of common standards.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.